Business
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo
The wearables in pharma & biotech market is forecasted to grow from USD 3.98 billion in 2026 to USD 9.97 billion by 2031, at a CAGR of 20.2%. This rapid growth is fueled by advances in biosensor technology, miniaturization, and digitization, supported by strong internet connectivity worldwide. Programs like "All of Us" and RPM adoption are boosting wearables' role in research and healthcare. CGMs lead product segments due to robust clinical backing, while pharma and biotech companies were top en
About this update from Abbott Laboratories
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The wearables in pharma & biotech market is forecasted to grow from USD 3.98 billion in 2026 to USD 9.97 billion by 2031, at a CAGR of 20.2%. This rapid growth is fueled by advances in biosensor technology, miniaturization, and digitization, supported by strong internet connectivity worldwide. Programs like "All of Us" and RPM adoption are boosting wearables' role in research and healthcare. CGMs lead product segments due to robust clinical backing, while pharma and biotech companies were top end-users in 2025. Asia Pacific is set for high growth, driven by digital health infrastructure and research activities. Key players include Abbott and Dexcom.","length":675,"tagName":"p"},{"type":"text","content":"Wearables in Pharma & Biotech Market","length":40,"tagName":"p"},{"type":"image","alt":"Wearables in Pharma & Biotech Market","displaySize":"","headline":null,"caption":"Wearables in Pharma & Biotech Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/01eece0031ab1129b9a6a41e39d8d320"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JvRDxqjlZxYbj2mw_eaQ9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/globenewswire.com/01eece0031ab1129b9a6a41e39d8d320","width":600,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/jWCx7yCJkV4pj5FpPsVkVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://media.zenfs.com/en/globenewswire.com/01eece0031ab1129b9a6a41e39d8d320","width":600,"height":400}}},{"type":"text","content":"Dublin, May 18, 2026...